Lupus erythematosus and the skin: A journey at times perplexing, usually complex, often challenging, and evermore exhilarating

Lupus

Volumn 19, Issue 9, 2010, Pages 1009-1011

  Obermoser, G ^a,b  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b Universitatsklinik fuer Dermatologie und Venerologie Innsbruck   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ANTIMALARIAL AGENT; BETA INTERFERON; CALCINEURIN INHIBITOR; CELL NUCLEUS ANTIGEN; CORTICOSTEROID; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; DOUBLE STRANDED DNA; INTERLEUKIN 18; RIBONUCLEOPROTEIN; RO ANTIBODY; TOLL LIKE RECEPTOR;

APOPTOSIS; B LYMPHOCYTE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EDITORIAL; HUMAN; IMMUNE COMPLEX DEPOSITION; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; SKIN LUPUS ERYTHEMATOSUS; SYMPTOM; T LYMPHOCYTE; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ANIMALS; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SKIN;

EID: 77955519934     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310373108     Document Type: Editorial

References (2)

1. Banchereau J., Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006 ; 25 (3). 383-392.
2. Obermoser G., Zelger B. Triple need for photoprotection in lupus erythematosus. Lupus 2008 ; 17 (6). 525-527.